Paul Tudor Jones’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.8M | Buy |
+195,391
| New | +$23.7M | 0.03% | 467 |
|
|
2025
Q4 | – | Sell |
-1,703
| Closed | -$311K | – | 3739 |
|
|
2025
Q3 | $245K | Sell |
1,703
-132,307
| -99% | -$16.2M | ﹤0.01% | 3101 |
|
|
2025
Q2 | $13.5M | Buy |
+134,010
| New | +$10.2M | 0.03% | 511 |
|
|
2024
Q4 | – | Sell |
-11,886
| Closed | -$856K | – | 3242 |
|
|
2024
Q3 | $868K | Buy |
+11,886
| New | +$877K | ﹤0.01% | 1709 |
|
|
2024
Q1 | – | Sell |
-23,044
| Closed | -$714K | – | 2472 |
|
|
2023
Q4 | $714K | Sell |
23,044
-2,373
| -9% | -$61.5K | 0.01% | 1610 |
|
|
2023
Q3 | $642K | Sell |
25,417
-13,661
| -35% | -$312K | 0.01% | 1549 |
|
|
2023
Q2 | $825K | Sell |
39,078
-30,180
| -44% | -$573K | 0.01% | 1415 |
|
|
2023
Q1 | $1.18M | Sell |
69,258
-3,723
| -5% | -$72.3K | 0.02% | 1093 |
|
|
2022
Q4 | $1.46M | Buy |
72,981
+10,790
| +17% | +$209K | 0.03% | 835 |
|
|
2022
Q3 | $1.34M | Buy |
62,191
+157
| +0.3% | +$3.76K | 0.03% | 741 |
|
|
2022
Q2 | $1.22M | Buy |
62,034
+16,664
| +37% | +$349K | 0.03% | 765 |
|
|
2022
Q1 | $1.07M | Buy |
45,370
+6,999
| +18% | +$163K | 0.03% | 885 |
|
|
2021
Q4 | $1.04M | Buy |
+38,371
| New | +$1.1M | 0.02% | 970 |
|
|
2020
Q1 | – | Sell |
-19,419
| Closed | -$464K | – | 1182 |
|
|
2019
Q4 | $464K | Buy |
19,419
+2,026
| +12% | +$41.2K | 0.02% | 744 |
|
|
2019
Q3 | $307K | Sell |
17,393
-33,068
| -66% | -$639K | 0.01% | 847 |
|
|
2019
Q2 | $1.29M | Buy |
50,461
+31,432
| +165% | +$876K | 0.04% | 451 |
|
|
2019
Q1 | $553K | Buy |
+19,029
| New | +$493K | 0.02% | 672 |
|
|
2018
Q2 | – | Sell |
-15,066
| Closed | -$339K | – | 1133 |
|
|
2018
Q1 | $339K | Buy |
15,066
+6,044
| +67% | +$159K | 0.01% | 692 |
|
|
2017
Q4 | $281K | Sell |
9,022
-26,647
| -75% | -$787K | 0.01% | 835 |
|
|
2017
Q3 | $1.11M | Buy |
35,669
+14,047
| +65% | +$268K | 0.03% | 353 |
|
|
2017
Q2 | $371K | Buy |
21,622
+5,955
| +38% | +$102K | 0.01% | 684 |
|
|
2017
Q1 | $274K | Sell |
15,667
-7,220
| -32% | -$111K | 0.01% | 1057 |
|
|
2016
Q4 | $303K | Sell |
22,887
-149
| -0.6% | -$2.03K | 0.01% | 1021 |
|
|
2016
Q3 | $334K | Sell |
23,036
-5,127
| -18% | -$64.2K | 0.01% | 952 |
|
|
2016
Q2 | $278K | Buy |
28,163
+6,610
| +31% | +$77.1K | 0.01% | 1216 |
|
|
2016
Q1 | $273K | Buy |
+21,553
| New | +$283K | 0.01% | 1342 |
|
|
2015
Q4 | – | Sell |
-18,238
| Closed | -$339K | – | 1742 |
|
|
2015
Q3 | $339K | Buy |
+18,238
| New | +$455K | 0.01% | 1015 |
|
|
2015
Q2 | – | Sell |
-27,175
| Closed | -$565K | – | 1576 |
|
|
2015
Q1 | $565K | Buy |
+27,175
| New | +$479K | 0.02% | 668 |
|
Other funds holding INSM
BBA
DGM
OAG
Paul Tudor Jones's INSM Position: Q2 2026 in Review
Paul Tudor Jones opened a new position in Insmed (INSM) in Q2 2026: 195,391 shares worth $20.8M. The stake represents 0.03% of the portfolio and ranks #467 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in INSM as recently as Q3 2025.
Paul Tudor Jones first reported a position in INSM in Q1 2015 and has held it in 28 quarters since. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- Paul Tudor Jones held 195,391 shares of Insmed worth $20.8M as of Q2 2026.
- Insmed was a new Paul Tudor Jones position in Q2 2026.
- Insmed made up 0.03% of Paul Tudor Jones's portfolio in Q2 2026, its #467 holding.
- Paul Tudor Jones first reported a position in Insmed in Q1 2015 and has held it in 28 quarters since.
- 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.